A study by Jung et al. showed that 1-stearoyl-sn-glycero-3-phosphocholine (LPC), one of the lysophosphatidylcholines, decreased HDAC3 expression and suppressed the binding of HDAC3 to the promotor of survivin in chronic myelogenous leukemia K562 cells in vitro (Jung et al., 2013). Here, HDAC3 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.